Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 84.23% is 114% above its 5-year average of -622.32%, near the high end of its 5-year range (-1472.52%–94.73%).
119.06% above its 12-month average of -441.97%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -507.20%.
NET PROFIT MARGIN
84.23%
NET PROFIT MARGIN AVG TTM
-441.97%
NET PROFIT MARGIN AVG 3Y
-760.16%
NET PROFIT MARGIN AVG 5Y
-622.32%
NET PROFIT MARGIN AVG 10Y
-870.52%
NET PROFIT MARGIN AVG 15Y
-649.29%
NET PROFIT MARGIN AVG 20Y
-432.23%
CURRENT VS TTM AVG
+119.06%
CURRENT VS 3Y AVG
+111.08%
CURRENT VS 5Y AVG
+113.53%
CURRENT VS 10Y AVG
+109.68%
CURRENT VS 15Y AVG
+112.97%
CURRENT VS 20Y AVG
+119.49%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+32496.15%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$884.97M
Net Profit Margin
84.23%
TTM Avg
-441.97%
3Y Avg
-760.16%
5Y Avg
-622.32%
Market Cap
$887.50M
Net Profit Margin
9.36%
TTM Avg
-0.92%
3Y Avg
-15.83%
5Y Avg
-8.95%
Market Cap
$887.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$870.81M
Net Profit Margin
-4994.86%
TTM Avg
-4994.86%
3Y Avg
-4994.86%
5Y Avg
-4994.86%
Market Cap
$867.03M
Net Profit Margin
-6.85%
TTM Avg
-13.95%
3Y Avg
-29.17%
5Y Avg
-39.83%
Market Cap
$857.16M
Net Profit Margin
-39.20%
TTM Avg
-57.59%
3Y Avg
-24.68%
5Y Avg
-1.42%
Market Cap
$855.38M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$914.73M
Net Profit Margin
6.60%
TTM Avg
6.45%
3Y Avg
5.72%
5Y Avg
5.15%
Market Cap
$853.13M
Net Profit Margin
116.30%
TTM Avg
67.23%
3Y Avg
16.07%
5Y Avg
4.15%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $884.97M | 84.23% | -441.97% | -760.16% | -622.32% |
| Bioventus Inc. (BVS)vs › | $887.50M | 9.36% | -0.92% | -15.83% | -8.95% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | -4994.86% | -4994.86% | -4994.86% | -4994.86% |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -6.85% | -13.95% | -29.17% | -39.83% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -39.20% | -57.59% | -24.68% | -1.42% |
| Alumis Inc. (ALMS)vs › | $855.38M | -5933.45% | -505.88% | -252.94% | -252.94% |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 6.60% | 6.45% | 5.72% | 5.15% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 116.30% | 67.23% | 16.07% | 4.15% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -173.85% | -104.63% | -54.62% | -54.62% |
Operating Margin
-192.1%
Net Profit Margin
84.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -507.20% |
| 2026-03-31 | 94.73% |
| 2025-12-31 | -357.37% |
| 2025-09-30 | -1463.52% |
| 2025-06-30 | 23.49% |
| 2025-03-31 | -1390.36% |
| 2024-12-31 | -796.19% |
| 2024-09-30 | -1472.52% |
| 2024-06-30 | -1146.93% |
| 2024-03-31 | -1166.78% |
| 2023-12-31 | -900.33% |
| 2023-09-30 | -431.60% |
| 2023-06-30 | -367.53% |
| 2023-03-31 | -244.34% |
| 2022-12-31 | -351.19% |
| 2022-09-30 | -295.14% |
| 2022-06-30 | -99.66% |
| 2022-03-31 | -125.31% |
| 2021-12-31 | -665.03% |
| 2021-09-30 | -573.59% |
| 2021-06-30 | -832.42% |
| 2021-03-31 | -775.25% |
| 2020-12-31 | -714.25% |
| 2020-09-30 | -1231.45% |
| 2020-06-30 | -930.45% |
| 2020-03-31 | -929.64% |
| 2019-12-31 | -1523.73% |
| 2019-09-30 | -2695.30% |
| 2019-06-30 | -3570.44% |
| 2019-03-31 | -3424.30% |
| 2018-12-31 | -1087.54% |
| 2018-09-30 | -1542.09% |
| 2018-06-30 | 248.47% |
| 2018-03-31 | -1213.72% |
| 2017-12-31 | -1417.96% |
| 2017-09-30 | -168.31% |
| 2017-06-30 | -1756.98% |
| 2017-03-31 | -7926.38% |
| 2016-12-31 | 112151.28% |
| 2016-09-30 | -2531.65% |
| 2016-06-30 | -42071.20% |
| 2016-03-31 | -2632.50% |
| 2015-12-31 | -41.49% |
| 2015-09-30 | -712.96% |
| 2015-06-30 | -438.24% |
| 2015-03-31 | -256.07% |
| 2014-12-31 | -141.79% |
| 2014-09-30 | -197.25% |
| 2014-06-30 | -335.78% |
| 2014-03-31 | -405.96% |
| 2013-12-31 | -34.70% |
| 2013-09-30 | -199.34% |
| 2013-06-30 | -106.02% |
| 2013-03-31 | -119.46% |
| 2012-12-31 | 1019.84% |
| 2012-09-30 | -112.71% |
| 2012-06-30 | -53.13% |
| 2012-03-31 | -88.66% |
| 2011-12-31 | -49.92% |
| 2011-09-30 | -35.32% |
| 2011-06-30 | -80.13% |
| 2011-03-31 | -71.32% |
| 2010-12-31 | -21.78% |
| 2010-09-30 | -25.85% |
| 2010-06-30 | -181.83% |
| 2010-03-31 | -179.14% |
| 2009-12-31 | -58.64% |
| 2009-09-30 | -86.39% |
| 2009-06-30 | -59.58% |
| 2009-03-31 | -72.05% |
| 2008-12-31 | -71.03% |
| 2008-09-30 | -142.83% |
| 2008-06-30 | -191.98% |
| 2008-03-31 | -22.74% |
| 2007-12-31 | 8.37% |
| 2007-09-30 | 26.34% |
| 2007-06-30 | -172.45% |
